3589 Healthcare courses

Course Duration: Full-day program (or two half-day modules), with options for virtual delivery or leadership retreats Target Audience: Mid to senior-level leaders, team managers, project leads, or high-potential employees who are responsible for leading through disruption, complexity, or organisational transformation. Course Objectives By the end of this course, participants will be able to: Understand the principles of adaptive leadership and why it's essential in unpredictable environments. Recognise the difference between technical and adaptive challenges. Build the mindset and behaviours needed to lead with resilience and flexibility. Engage and empower teams in the face of uncertainty and resistance. Apply practical tools to lead through change, conflict, and complexity. Course Outline Module 1: Understanding Adaptive Leadership What is adaptive leadership? Origins (Harvard Kennedy School, Ronald Heifetz model) How adaptive leadership differs from traditional leadership The link between complexity, uncertainty, and the need for adaptability Module 2: The Nature of Change and Challenge Technical vs adaptive challenges Why some problems can’t be solved with expertise alone Common leadership traps during crisis or disruption Adaptive work: reframing problems and shifting mindsets Module 3: The Core Principles of Adaptive Leadership Get on the balcony – seeing the bigger picture Regulate distress – maintaining productive tension Maintain disciplined attention – keeping teams focused Give the work back – empowering others to lead Protect voices of leadership from below – enabling diverse input Module 4: Leading Yourself Through Uncertainty Developing personal resilience and emotional agility Navigating ambiguity, setbacks, and pressure Identifying your leadership default style under stress Reflection: What kind of leader does your team need now? Module 5: Engaging Others in Times of Uncertainty Building trust and psychological safety during turbulence Managing resistance to change with curiosity and empathy Tools for courageous conversations and adaptive dialogue Creating shared purpose and distributed leadership in teams Module 6: Adaptive Tools and Techniques Scenario planning and sensemaking Stakeholder mapping in dynamic environments Using inquiry over advocacy Holding space for experimentation and learning Leading with both confidence and humility Module 7: Action Planning and Application Identify one adaptive challenge in your role/team Map your adaptive leadership response Peer coaching conversations Build a 30-day Adaptive Leadership Plan Delivery Style Workshop-style, highly interactive Case studies, breakout discussions, and guided self-reflection Scenario-based practice and small group exercises Option to include pre-work, post-session coaching or check-ins Course Materials Provided Adaptive Leadership workbook Reflection tools and leader self-assessment Conversation guide for adaptive challenges Change resistance diagnostic Personal Leadership Development Plan template Optional Add-ons Executive coaching package 360 feedback or team diagnostic on adaptive capacity Integration with change management or innovation programs Customisation for specific industries (e.g., public sector, healthcare, education, finance)

Proactive risk management is a major component of good pharmacovigilance practice. This module sets out the principles of risk management planning and outlines regulatory requirements for risk management plans in regions that are major markets for medicinal products.

A 505(b)(2) New Drug Application (NDA) is a submission to the Food and Drug Administration (FDA) for approval to market a drug in the USA. It differs from a ‘stand-alone’ NDA in that some of the data on which the applicant relies to demonstrate safety and efficacy have been obtained from publicly available sources rather than from the applicant’s own studies. The applicant typically proposes to market a drug that is based on an approved reference product but modified in its formulation or uses. A 505(b)(2) NDA also differs from an Abbreviated New Drug Application (ANDA) for approval of a generic drug in that the applicant’s product need not be a duplicate of the reference listed drug. The 505(b)(2) pathway may be said to lie part-way between the ‘stand-alone’ NDA and generics pathways, offering a unique combination of advantages to developers. It facilitates the modification of drugs to address unmet medical needs. The 505(b)(2) application pathway accounts for about half of all new drug approvals in the USA.

Unlock the keys to optimal health for older adults with our Geriatric Nutrition Course: Health & Dietary Strategies. Master the essentials of nutritional assessment, dietary interventions, and specialized care for the aging population. Join us in promoting healthy aging, preventing malnutrition, and navigating the nuances of food safety and medication interactions. Elevate your expertise in geriatric nutrition and make a positive impact on the well-being of seniors. Enroll now for evidence-based insights and practical strategies in senior healthcare.

This course enables providers and their staff to develop an understanding of the responsibilities and duties around the Mental Capacity Act 2005 (MCA). This essential training is for workers involved in the care, treatment and support of adults who may lack capacity in making life decisions. This training offers vital support for social care providers, so they comply with the Mental Capacity Act and Care Quality Commission requirements and promote human rights.

This course aims to give the learner the knowledge regarding conditions, causes, signs, symptoms, treatments and risks associated with respiratory diseases.

Boost your medical career! Master clinical coding, ace medical administration. Enhance patient care, be a healthcare ace. Start your transformative journey now!

This course provides both underpinning knowledge of stoma care and practical techniques to deliver person centred support for someone who requires stoma care.

Pharmaceutical, biotechnology and medical device companies and clinical researchers need to assure regulatory authorities of the reliability of the data that they generate during product development and testing – that is, to demonstrate data integrity. Practices that provide assurance of data integrity in clinical research are required by law and/or established as expectations in regulatory guidance. The data are reviewed in regulatory applications or during regulatory inspections of clinical trial sponsor and investigational sites. Inadequacies of data integrity are frequently reported by inspectors and result in regulatory actions against the organizations or individuals concerned. This course explains the requirements and describes principles and practices that should be followed by trial sponsors, investigators and other clinical research personnel to assure regulators of data integrity.

Pharmaceutical and biotechnology companies and researchers need to assure regulatory authorities of the reliability of the data that they generate or acquire during product development and manufacturing – that is, to demonstrate data integrity. Data integrity is assessed during regulatory inspections of manufacturing and research sites. Inadequacies of data integrity are frequently reported by inspectors and result in regulatory actions against the companies or individuals concerned. Practices that assure data integrity are required by law and/or expected by regulators in the fields of nonclinical and clinical research, manufacturing and distribution, and pharmacovigilance of medicinal products. This course explains the requirements and describes principles and practices that should be followed to assure regulators and contractual partners of data integrity in the manufacture of medicinal products.